Integrated DNA Technologies expands global sales network
Company now selling directly to customers in South Korea
Integrated DNA Technologies (“IDT”) acquired MBiotech, Inc. (“MBiotech”), headquartered in Seoul, South Korea. MBiotech has been a distributor of IDT products for more than a decade.
In its promotion of IDT products, MBiotech has successfully made IDT’s brand well-known throughout South Korea. The company also distributes products for other manufacturers. These other products include reagents, enzymes, kits, consumables and lab equipment. Moving forward, IDT will continue MBiotech’s distribution activities of other manufacturers’ products and plans to keep day-to-day operations unchanged.
Dr Joseph A. Walder, IDT founder and chief executive officer, commented, “IDT has enjoyed a long-standing relationship with MBiotech. We respect and welcome them into the company. MBiotech’s local-language website, efficient operations, and extensive distributor base make it a valuable asset.”
Joshua Lee, founder, president and CEO of MBiotech said, “We share IDT’s commitment to excellent customer service and quality. We are very pleased to become part of the IDT family. As one company, we will be able to offer better service to our Korean customers and those in our global markets.”
Other news from the department business & finance

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
More news from our other portals
Last viewed contents
Fluidigm-Singapore completes final milestone toward full manufacturing operations - Off-shore fab positions Fluidigm to move rapidly into the real-time qPCR market
Eppendorf grows faster than the market
Biotie announces start of tozadenant Phase 3 Study in Parkinson's disease
ZEISS: High-Tech Drives Growth - Medical technology and industrial metrology business still on track for growth

Innophore GmbH - Graz, Austria
OctoPlus appoints Jan Hendrik Egberts as CEO

Microscaffolds – a New Strategy in Tissue Engineering - Living cells meet high-resolution 3D printing process

Merck Appoints New Executive Board Members - Bernd Reckmann to retire

Evotec adds cell therapy manufacturing facility with acquisition of Rigenerand
Molecular Partners enters into a Strategic Research Collaboration and Option Agreement with Janssen Biotech, Inc.
AlgoNomics appoints Philippe Stas as CEO - Founder Dr. Ignace Lasters remains CSO and director of the company
